[{"Assets_0_Q3_USD":209255000.0,"CommonStockSharesOutstanding_0_Q3_shares":31109000.0,"NetIncomeLoss_1_Q3_USD":-20706000.0,"NetIncomeLoss_3_Q3_USD":-57172000.0,"StockholdersEquity_0_Q3_USD":194651000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]